- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nonalcoholic Fatty Liver in France
Total 1167 results
-
Assistance Publique - Hôpitaux de ParisCompletedNonalcoholic Fatty Liver Disease (NAFLD)France
-
Hepion Pharmaceuticals, Inc.CompletedFibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Rennes University HospitalCompletedFatty Liver | Non-alcoholic Fatty Liver DiseaseFrance
-
Merck Sharp & Dohme LLCRecruitingNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, NonalcoholicCanada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo...
-
University Hospital, Strasbourg, FranceUnknownNonalcoholic Fatty Liver DiseaseFrance
-
Mativa-Tech SARecruitingNASH - Nonalcoholic SteatohepatitisFrance
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
University Hospital, GrenobleInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement...RecruitingHBV | NASH - Nonalcoholic SteatohepatitisFrance
-
Promethera TherapeuticsCompletedNASH - Nonalcoholic SteatohepatitisSpain, Belgium, Bulgaria, France
-
Merck Sharp & Dohme LLCCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
CymaBay Therapeutics, Inc.TerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States
-
Aligos TherapeuticsCompletedNASH - Nonalcoholic SteatohepatitisFrance
-
Terns, Inc.Completed
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
University Hospital, LilleMinistry of Health, FranceRecruitingObesity | Cirrhosis | Surgery | NASH - Nonalcoholic SteatohepatitisFrance
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
Meridian Bioscience, Inc.Conatus PharmaceuticalsCompletedCirrhosis | Portal Hypertension | NASH - Nonalcoholic SteatohepatitisFrance
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
Viking Therapeutics, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
GlaxoSmithKlineRecruitingNonalcoholic Fatty Liver DiseaseUnited States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD)United States, Japan
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNAFLD | Nonalcoholic Steatohepatitis (NASH) | Fibrosis, LiverUnited States, France, Mexico
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
Bristol-Myers SquibbTerminatedNonalcoholic Fatty Liver DiseaseUnited States
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Tokyo Medical UniversityRecruitingNonalcoholic Steatohepatitis | Elastography | UltrasoundUnited States, Korea, Republic of, Germany, Italy, China, France, Japan, United Kingdom
-
Zydus Therapeutics Inc.CompletedNonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
University Hospital, LilleRégion Nord-Pas de Calais, France; RHU PreciNASH Task 1.4RecruitingObesity | NASH - Nonalcoholic SteatohepatitisFrance
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsActive, not recruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverUnited Kingdom, Finland, Sweden, Spain, Greece, United States, Switzerland, Italy, France, Germany
-
HighTide Biopharma Pty LtdCompletedDigestive System Diseases | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM) | Fatty Liver, NonalcoholicUnited States
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD) | Hepatic CirrhosisUnited States, Japan
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Eli Lilly and CompanyCompletedNonalcoholic SteatohepatitisUnited States, Spain, Japan, United Kingdom, Belgium, France, Italy, Israel, Mexico, Poland
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
Aligos TherapeuticsRecruitingNonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated SteatohepatitisUnited States
-
Central Hospital, Nancy, FranceEli Lilly and CompanyNot yet recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisFrance
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland